about
Colorectal Manifestation of Follicular LymphomaDiagnosis of follicular lymphoma of the gastrointestinal tract: A better initial diagnostic workupRecurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease.Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome.Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group.Spontaneous regression of plasmablastic lymphoma in an elderly human immunodeficiency virus (HIV)-negative patient.CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential.Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series.The Clinical and Hormonal Characteristics of Primary Adrenal Lymphomas: The Necessity of Early Detection of Adrenal InsufficiencyEndoscopic detection of the gastric lesions of peripheral T-cell lymphomaGraft-versus-leukemia effect with a WT1-specific T-cell response induced by azacitidine and donor lymphocyte infusions after allogeneic hematopoietic stem cell transplantation.Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma.Vigorous inflammatory responses in noninfectious pulmonary complication induced by donor lymphocyte infusion.High-dose chemotherapy and autologous peripheral blood stem cell transplantation for treatment of unspecified peripheral T-cell lymphoma presented with hepatosplenomegaly and hypercytokinemia syndrome: report of three cases.Establishment and characterization of a novel ALL-L3 cell line (BALM-18): induction of apoptosis by anti-IgM and inhibition of apoptosis by bone marrow stroma cells.Recurrence after radiotherapy for gastric mucosa-associated lymphoid tissue (MALT) lymphoma with trisomy 18.Filarial chyluria as a rare cause of urinary retention.High-dose chemotherapy with autologous stem cell transplantation for elderly patients with relapsed/refractory diffuse large B cell lymphoma: a nationwide retrospective study.Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host disease.Retroviral vector backbone immunogenicity: identification of cytotoxic T-cell epitopes in retroviral vector-packaging sequences.Identification of native, immunogenic peptides from Cyclin D1.Phenotypic analysis of peripheral T/NK cell lymphoma: study of 408 Japanese cases with special reference to their anatomical sites.Reply to "The Difficulty in Administering Appropriate Antimicrobial Therapy for Stenotrophomonas maltophilia Bacteremia".Reduced neurotoxicity with combined treatment of high-dose methotrexate, cyclophosphamide, doxorubicin, vincristine and prednisolone (M-CHOP) and deferred radiotherapy for primary central nervous system lymphoma.Novel and simple prognostic index for nasal natural killer/T-cell lymphoma.Using CD40-activated B cells to efficiently identify epitopes of tumor antigens.Cyclin D1-specific cytotoxic T lymphocytes are present in the repertoire of cancer patients: implications for cancer immunotherapy.Hyperintense Lesion in the Pons in Intravascular Lymphoma.The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells.Recurrent Stenotrophomonas maltophilia bacteremia after iliac crest bone graft harvest.Mammalian target of rapamycin inhibitors permit regulatory T cell reconstitution and inhibit experimental chronic graft-versus-host disease.Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantationHLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcomeNodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patientsRecurrent idiopathic iridocyclitis after autologous peripheral blood stem-cell transplantation followed by G-CSF administration for acute lymphoblastic leukemiaCentroblastic and centroblastic/centrocytic lymphoma associated with a prominent epithelioid granulomatous response: a clinicopathologic study of 50 casesEfficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cells
P50
Q26771347-27BC775C-68AE-4173-B861-1E66B0988F2FQ26773194-1DA17F7C-A6A8-4425-8367-4755C2861FC3Q27853366-5FDBD934-136B-4D9C-B572-87199F6BB94CQ33408659-122281A6-4043-42D5-BBA2-EE152432C8A9Q33428744-32C46BFD-A707-4AAC-AA79-F4DF04523133Q33429461-06003772-AB1B-496F-9E67-D246065D9ECEQ33439399-04B02461-3D78-4121-A68F-FCBB4084CF50Q34454611-C202F37D-1140-4B56-9ACD-839A69447AC0Q36131098-BA93BFAD-80A9-4B0A-83C8-08B531ED891DQ37336918-8F8F3B67-2DFF-488B-96C3-9F6A87F99B2CQ37681071-7EAC9B0B-5BC8-4659-9E9E-5AB726942836Q38631602-C37B85C7-CCC8-4C55-8ED6-5376E4D43DB5Q38784407-C199B6D1-9777-47BA-89AB-16B3AB312358Q38990246-0E79ECB4-1C80-4931-8E51-DC7A3CE3CAE5Q39040484-B4F1BC85-1AC8-4C77-8B4E-51ED1FDA7039Q40135885-1DF702E6-1F34-43F1-94E3-DD5939296340Q40571175-AC58887B-C05B-4263-95F2-D6B3EA36A96EQ40947239-C8A6B3EC-4C55-44F2-B3AC-75BF6AAA1823Q41332137-AFA5940F-245E-4B77-8DA4-2F25BC5DCB2EQ41759954-FF9E983D-C991-469C-968D-F42834CA0DCBQ42229931-CEDED217-43B4-4CF6-8068-52FF6A46490EQ42463266-49C6348E-9B9E-4E04-B2F1-7B5B02C20F81Q42824309-93A75C62-7EC0-4D78-BB8A-44846B761D13Q44399322-DDCAE177-3865-4620-9058-D938F3B31858Q44465828-95A1A02C-E682-4247-8974-B0ABD8CF6B6AQ47117315-8F36E3DD-ED64-4471-B326-93B0D866C4F0Q48430365-56D8D9B6-4B1F-41EA-B938-0BE24818E7FBQ50895748-CD574D0F-B5C7-45F3-B33C-5732D55281F8Q51803494-ED81D94C-8CC1-4F0F-B49D-B92F3F6DAF69Q51866457-73AA792C-CC53-4EC5-B011-78FF30460880Q52149268-70863581-2CBE-4FEB-8BAF-2EA81CF7E212Q53377737-0E679999-A02F-408A-9065-98FEB01C24DDQ54195957-E8683516-4B6A-4FCB-8151-201D5CF339B0Q54390896-0FE7D9E0-4560-41C9-AD51-5FE0F051C67FQ58605816-9C817AD5-B6F0-4F73-B8E4-0B3050C513BAQ64074972-E3B73143-F94A-4527-A3FF-1B8FE5E07141Q73090387-2A8C3DA0-3C62-4B00-8C1D-0FC37EF96F83Q73932408-6B7409D5-DE54-4CB0-A202-7AEC894915C6Q74462567-1AD2FA8A-4A1C-43C9-ABC4-EE954ED12E54Q74583327-87E7DAC6-47EA-4029-9205-572EA4299F5D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eisei Kondo
@ast
Eisei Kondo
@en
Eisei Kondo
@es
Eisei Kondo
@nl
type
label
Eisei Kondo
@ast
Eisei Kondo
@en
Eisei Kondo
@es
Eisei Kondo
@nl
prefLabel
Eisei Kondo
@ast
Eisei Kondo
@en
Eisei Kondo
@es
Eisei Kondo
@nl
P106
P1153
7101748690
P31
P496
0000-0003-0995-9405